Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-05-31 @ 12:35 PM
Study NCT ID:
NCT01622660
Status:
TERMINATED
Last Update Posted:
2017-08-22
First Post:
2012-06-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
11-191
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |